Rubicon Research IPO Allotment: The initial public offering (IPO) of Rubicon Research Limited closed for public bidding on October 13, with a robust response from the investors. The issue witnessed an overall subscription of 103.90 times at the end of the session, as per the provisional exchange data.Â
The company aims to raise Rs 1377.50 crore from the public offering of 2.84 crore equity shares.
The basis of allotment is likely to be finalised today, October 14, followed by the credit of shares in the respective demat accounts of the successful subscribers. The stock is expected to list on the Dalal Street on October 16, 2025.
Add Zee Business as a Preferred Source
Investors can check their allotment status online on the websites of BSE, NSE, or the issue registrar, MUFG Intime India.
Here’s how you can check your allotment status online step-by-step:
Rubicon Research IPO allotment status on the BSE website:
1) Visit the BSE website
2) Select ‘Equity’ as the issue type
3) Choose ‘Rubicon Research Ltd.’ from the dropdown menu
4) Enter your application number or PAN
5) Click search to view your allotment status
Read More:Â Canara Robeco AMC IPO Allotment Date Time: Here’s how to check allotment status step-by-step
Rubicon Research IPO allotment status on the NSE website:
1) Visit the NSE website
2) Select ‘Equity & SME IPO bid details’
3) Choose ‘Rubicon Research Ltd.’ from the dropdown list
4) Enter your PAN and application number
5) Click submit
Rubicon Research IPO allotment status on the issue registrar’s website (MUFG Intime India):
1) Visit the MUFG Intime India website
2) Select ‘Rubicon Research Limited’ from the dropdown menu
3) Enter your PAN, application number, or DP/Client ID
4) Click submit
Read More:Â Canara HSBC Life Insurance IPO Final Day: Issue subscribed 29% so far, should you apply? Check for key details
Rubicon Research IPO subscription highlights:
Overall, investors bid for 170.96 crore shares against the total shares on offer, with a significant demand from institutional buyers.
Categorically, Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs) and Retail Individual Investors (RIIs) booked the issue 130.26 times, 97.61 times, and 35.47 times against their allotted portions, respectively.
Rubicon Research IPO details:
The Rubicon Research IPO is a book-building issue of Rs 1,377.50 crore, including a fresh issue of 1.03 crore equity shares of Rs 500 crore and an offer for sale (OFS) of 1.80 crore equity shares of Rs 877.50 crore.
The company plans to utilise the IPO proceeds for debt repayment, funding inorganic growth and for general corporate purposes.
Price band: Rs 461 to Rs 485 per equity share
Face value: Re 1 each
Subscription date: October 9 to October 13, 2025
Lot size: 30 shares
Minimum investment: Rs 14,550 (based on the upper end of the price band)
Listing date: October 16 on BSE and NSE
Read More:Â Midwest IPO opens on October 15 – 5 key things you should know before applying
Rubicon Research company profile:
Rubicon Research Limited is a pharmaceutical formulations company with a strong presence in regulated markets, particularly the United States.
The company has a portfolio of 66 commercialised products and 72 active ANDAs and NDAs approved by the US FDA.
